HealthSTAT News
STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
Eli Lilly’s Jaypirca has won FDA approval for previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Eli Lilly’s Jaypirca has won FDA approval for previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma.
Join the argument
House rules →Comments load as you scroll.